Up a level |
Ramanan, AV, Hampson, LV, Lythgoe, H, Jones, AP, Hardwick, B, Hind, H, Jacobs, B, Vasileiou, D, Wadsworth, I, Ambrose, N et al (show 11 more authors)
(2019)
Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design: An example of a proposed trial of adalimumab versus pamidronate for children with CNO/CRMO.
PLOS ONE, 14 (6).
e0215739-.
Lythgoe, H, Morgan, T, Heaf, E, Lloyd, O and Beresford, MW ORCID: 0000-0002-5400-9911
(2016)
EVALUATION OF THE ACR AND SLICC CLASSIFICATION CRITERIA IN JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS: A LONGITUDINAL ANALYSIS.
.
Lythgoe, H, Morgan, T, Heaf, E, Lloyd, O, Al-Abadi, E, Armon, K, Bailey, K, Davidson, J, Friswell, M, Gardner-Medwin, J et al (show 10 more authors)
(2017)
Evaluation of the ACR and SLICC classification criteria in juvenile-onset systemic lupus erythematosus: a longitudinal analysis.
LUPUS, 26 (12).
pp. 1285-1290.
Price, V, Lythgoe, H, Oni, L and Hawcutt, D ORCID: 0000-0002-8120-6507
(2016)
G261 Prescribing practices of rituximab in children: a 5-year retrospective review.
.
Lythgoe, H, Price, V, Beresford, MW, Peak, M and Hawcutt, D ORCID: 0000-0002-8120-6507
(2016)
G90(P) Research exposure for UK junior paediatric trainees.
.
Smith, EM, Lythgoe, H and Hedrich, CM ORCID: 0000-0002-1295-6179
(2019)
Vasculitis in juvenile-onset systemic lupus erythematosus.
Frontiers in Pediatrics, 7 (APR).
149-.